Measuring the Return on Modeling and Simulation Tools in Pharmaceutical Development – an IDC
White Paper

Based on in-depth interviews with research scientists in pharmaceutical development, market research firm IDC concludes that there is a significant return on investment (ROI) to be realized from the use of modeling and simulation software tools. The research was based on conversations with researchers at major pharmaceutical companies and academia and suggests a cumulative ROI of the order of $3–10 for every $1 invested in these tools.

The ROI varies based on type of users (occasional or power). In addition, the white paper identified additional areas of benefits that would also impact the ROI:

Increased experimental efficiency
Broader and deeper exploration of solution and new products
Improved productivity from the identification of workarounds for stalled projects
Improved time to market for new products, which translates to financial gains

In order to receive a complimentary copy of this paper via e-mail, please fill out the form below:

Contact Information

First Name*
(Required)
Last Name*
(Required)
Organization*
(Required)
Organization Type*
(Required)
Address 1*
(Required)
Address 2
(Required)
City*
(Required)
State/Province (US/Canada only)*
(Required)
State/Province (other)
(Required)
Zip/Postal Code*
(Required)
Country*
(Required)
Phone*
Required: a valid telephone number (no letters)
Fax
Required: a valid telephone number (no letters)
Email*
Required: a valid email address

Disclaimer

Accelrys will store the data you have provided in a database which is accessible by appropriate personnel who have a business need for the information. For full details on our privacy policy please see http://accelrys.com/company/legal/

Accelrys may contact me by e-mail with updates and information on products or services

Accelrys may share the information I have provided with its strategic partners, who may contact me about related products or services

Measuring the Return on Modeling and Simulation Tools in Pharmaceutical Development – an IDC White Paper

Measuring the Return on Modeling and Simulation Tools in Pharmaceutical Development – an IDC
White Paper